Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment

References

• Atema A., Buurman K. J. H., Noteboom E., Smets L. A. Potentiation of DNA-adduct formation and cytotoxicity of platinum—containing drugs by low pH. International Journal of Cancer 1993; 54: 166–172
   PubMed Web of Science ®Google Scholar
• Boitrel M. T. D., Pelletier H., Genne P., Petit J. M., Le Grimellec C., Canal P., Ardiet C., Bastian G., Chauffert B. Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. International Journal of Cancer 1992; 50: 677–682
   PubMedGoogle Scholar
• Bowden G. T., Kasunic M., Dim D. Sequence dependence for the hyperthermic potentiation of cis-diaminedichloroplatinum(II) induced cytotoxicity and DNA damage. Proceedings of the 3rd NAGH. 1983; 161–162
   Google Scholar
• Canon J. L., Humblet Y., Symann M. Resistance to cisplatin: How to deal with the problem?. European Journal of Cancer 1990; 26: 1–3
   PubMed Web of Science ®Google Scholar
• Dasilva V. F., Raaphorst G. P., Goyal R., Feeley M. M. Drug cytotoxicity at elevated temperature. Journal of Neurosurgery 1987; 67: 83–88
   Google Scholar
• Douple E. G., Strohbehn J. W., Desieyes D. C., Alborough D. P. Therapeutic potentiation of cis-diaminedichloroplatinum in a mouse tumour. National Cancer Institute Monograms 1982; 61: 259–262
   Google Scholar
• Eastman A., Schulte N. Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum(II). Biochemistry 1988; 27: 4730–4734
   PubMed Web of Science ®Google Scholar
• Eichholtz-Wirth H., Hietel B. Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia 1990; 6: 47–55
   PubMed Web of Science ®Google Scholar
• Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 136–203
   PubMedGoogle Scholar
• Fraval H. N. A., Roberts J. J. G1 Phase Chinese Hamster V79–379A cells are inherently more sensitive to platinum bound to their DNA than mid S Phase or asynchronously treated cells. Biochemical Pharmacology 1979; 28: 1575–1580
   PubMedGoogle Scholar
• Hahn G. M. Potentiation of therapy drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
   PubMed Web of Science ®Google Scholar
• Hamilton T. C., Lai G. M., Rothenberg L. M., Fojo A. T., Young R. C., Ozols R. F. Mechanisms of resistance to cisplatin and alkylating agents. Drug Resistance in Cancer Therapy, R. F. Ozols. Kluwer Academic Publishers, Boston 1989
   Google Scholar
• Herman T. S., Sweets C. C., White D. M., Gerner E. W. Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. Journal of the National Cancer Institute 1982; 68: 487–492
   PubMedGoogle Scholar
• Herman T. S., Teicher B. A., Cathcart F. N. S., Kaufman M. E., Lee J. B., Lee M. Effect of hyperthermia on cisdiaminedichloroplatinum(II) and pt(Rh-123) in a human squamous carcinoma cell line and a cisplatin resistant subline. Cancer Research 1988; 48: 5101–5105
   PubMed Web of Science ®Google Scholar
• Konings A. W. T., Hettinga J. V. E., Lemstra W., Humphrey G. B., Kapinga H. H. Sensitizing for cisplatin action by hyperthermia in resistant cells. International Journal of Hyperthermia 1993; 9: 553–562
   PubMed Web of Science ®Google Scholar
• Krishnaswamy G., Dewey W. C. Cell killing and chromosomal aberrations induced in Chinese hamster ovary cells by treating with Cisplatin at 41·5°C during G1 or late S phase. Cancer Research 1993; 53: 1239–1243
   PubMedGoogle Scholar
• Kubota N., Kakehi M., Inada T. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant cells grown as monolayer cultures and multicellular spheroids. International Journal of Radiation Oncology 1993; 25: 491–497
   Google Scholar
• Lai G. M., Ozols R. F., Smyth J. F., Young R. C., Hamilton T. C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochemical Pharmacology 1988; 37: 4597–4600
   PubMed Web of Science ®Google Scholar
• Laurencot C. M., Kennedy K. A. Cisplatin Toxicity in EMT6 mouse mammary tumour cells after alterations in extracellular pH and intracellular pH. Proceedings of the Annual Meeting of the American Association of Cancer Research 1992; 33: A3212
   Google Scholar
• Masuda H., Tanaka T., Kido A., Kitamura K., Kusaba I. Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer Journal 1991; 4: 283–287
   Google Scholar
• Meijer C., Mulder N. H., Hospers G. A. P., Uges D. R. A., De Vries E. G. E. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. British Journal of Cancer 1990; 62: 72–77
   PubMed Web of Science ®Google Scholar
• Micetich K., Zwelling L., Kohn K. W. Quenching of DNA: platinum(II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum(II) in L1210 cells. Cancer Research 1983; 43: 3609–3613
   PubMedGoogle Scholar
• Miyahara T., Ueda K., Akaboshi M., Shimada Y., Imamura M., Utsumi H. Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum(II) in cultured human esophageal cancer cells. Japan Journal of Cancer Research 1993; 84: 336–346
   PubMedGoogle Scholar
• Supi G., Badaracco G., Cavatiere R., Natali F. G., Gerco C. Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncology 1994; 1: 429–431
   Google Scholar
• Tashiro T., Sato Y. Chracterization of acquired resistance to cis-diaminedichloroplatinum(I) in mouse leukemia cell lines. Japan Journal of Cancer Research 1992; 83: 219–225
   PubMedGoogle Scholar
• Urano M., Kahn J., Kenton L. A. The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. International Journal of Hyperthermia 1990; 6: 563–570
   PubMed Web of Science ®Google Scholar
• Wallner K. E., Li G. C. Effect of drug exposure duration and sequencing on Hyperthermic potentiation of Metomycin-C and Cisplatin. Cancer Research 1987; 47: 493–495
   PubMed Web of Science ®Google Scholar
• Westermark B., Ponten J., Hugossen R. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathology Microbiology Scandinavia 1973; 81: 791–805
   Google Scholar